Patents by Inventor Susan Reutzel-Edens

Susan Reutzel-Edens has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

CRYSTALLINE 2,5-DIONE-3-(1-METHYL-1H-INDOL-3-YL)-4-[1-(PYRIDIN-2-YLMETHYL) PIPERIDIN-4-YL]-1H-INDOL-3-YL]-1H-PYRROLE MONO-HYDROCHLORIDE

Publication number: 20070270465

Abstract: The present invention relates to crystalline 2,5-dione-3-(1-methyl-1H-indol-3-yl)-4-[1-(pyridin-2-yl-methyl)piperidin-4-yl)]-1H-pyrrole mono-hydrochloride salt, a pharmaceutical formulation containing said salt and to methods for treating cancer and for inhibiting tumor growth using said salt.

Type: Application

Filed: July 11, 2007

Publication date: November 22, 2007

Inventors: Julie Bush, Margaret Faul, Susan Reutzel-Edens
NOVEL SALT AND CRYSTALLINE FORMS OF (2R)-ANTI-5-{3-[4-(10,11-DIFLUOROMETHANODIBENZOSUBER-5-YL)PIPERAZIN-1-YL]-2-HYDROXYPROPOXY}QUINOLINE

Publication number: 20070244124

Abstract: The present invention provides novel salt and hydrate crytal forms of (2R)-anti-5- {3-[4 -(10,11-difluoromethano-dibenzosuber-55yl]-2-hydroxypropoxy}quinoline 2.5 hydrochloride.

Type: Application

Filed: May 24, 2007

Publication date: October 18, 2007

Applicant: ELI LILLY AND COMPANY

Inventors: Julie Bush, Susan Reutzel-Edens
Novel crystalline forms of {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1h-[1,2,3] triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone

Publication number: 20070078166

Abstract: The present invention provides novel crystalline forms of {2-[1-(3,5-bistrifluoromethylbenzyl)-5-pyridin-4-yl-1H-[1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone, compositions thereof, intermediates thereof, methods of using the same, processes for making the same, and processes for making intermediates thereof.

Type: Application

Filed: October 12, 2004

Publication date: April 5, 2007

Applicant: Eli Lilly and Company Patent Division

Inventors: Alfio Borghese, David Coffey, Pamela Footman, Steven Pedersen, Susan Reutzel-Edens, Shella Tameze, Carsten Timpe, Carsten Weber
Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2ylmethyl)piperidin-4-yl]-1h- pyrrole mono-hydrochloride

Publication number: 20050288332

Abstract: The present invention relates to crystalline 2,5-dione-3-(1-methyl-1H-indol-3-yl)-4-[1-(pyridin-2-yl-methyl)piperidin-4-yl]-1H-indol-3-yl]-1H-pyrrole mono-hydrochloride salt, a pharmaceutical formulation containing said salt and to methods for treating cancer and for inhibiting tumor growth using said salt.

Type: Application

Filed: July 8, 2003

Publication date: December 29, 2005

Inventors: Julie Bush, Margaret Faul, Susan Reutzel-Edens

CRYSTALLINE 2,5-DIONE-3-(1-METHYL-1H-INDOL-3-YL)-4-[1-(PYRIDIN-2-YLMETHYL) PIPERIDIN-4-YL]-1H-INDOL-3-YL]-1H-PYRROLE MONO-HYDROCHLORIDE

NOVEL SALT AND CRYSTALLINE FORMS OF (2R)-ANTI-5-{3-[4-(10,11-DIFLUOROMETHANODIBENZOSUBER-5-YL)PIPERAZIN-1-YL]-2-HYDROXYPROPOXY}QUINOLINE

Novel crystalline forms of {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1h-[1,2,3] triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone

Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2ylmethyl)piperidin-4-yl]-1h- pyrrole mono-hydrochloride